HUARENA
HUARENA
Huaren Pharmaceutical was founded in May 1998. It is a modern pharmaceutical and health industry group integrating R&D, production and sales, mainly focusing on preparations, raw materials, pharmaceutical packaging materials and medical devices.
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, with the stock abbreviation "Huaren Pharmaceutical" and the stock code "300110". In July 2019, the company made an equity change, and the Xi'an Qujiang New District Management Committee became the actual controller of the company.
After more than 20 years of development, the company's business focuses on the fields of nephrology, respiratory medicine, anaesthesia and large-capacity preparations, and has successively built five major production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags. (bottle), all production lines have passed the new version of GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, big health products and raw materials, etc., and currently available Pentazocin injection, doxotheline injection, glycerol fructose sodium chloride injection, low-calcium peritoneal dialysate, etc., has achieved the "raw materials + preparations + pharmaceutical packaging materials" Integrated development.
Taking innovation as the soul of development, in recent years, the company has actively grasped strategic development opportunities, focused on the treatment direction of nephrology, respiratory medicine, and semen anesthetics, screened new varieties such as large-capacity preparations, benchmarked against domestic and foreign first-line enterprises, and continued to increase R&D Invest, enrich R&D pipelines, enrich product lines, and enhance sustainable development capabilities.
In the future, the company will actively respond to the national "Healthy China" strategy, support the construction of product strength, and actively promote the strategic layout of medical and health through independent research and development and collaborative innovation, and strive to grow into a combination of raw materials, preparations, medical devices, A pharmaceutical and health industry group that develops in a coordinated manner in pharmaceutical packaging materials and other sectors.
Brand: FOSHAN PHARMA
Main Products: Tetanus Antitoxin Injection , Tetanus Antiserum , Human Hepatitis B Immunoglobulin , Oxytocin Injection , Natural essential oil , Biological Product For Human
Shaanxi YXchuang Biotechnology Co., Ltd
Brand: YXchuang
Main Products: API Powder , Pharmaceutical Intermediates , Vitamins Powder , Plant Extracts , Food Additive , Peptide Powder
Brand: NOUVASANT
Main Products: Finished Pharmaceutical Product , API & Raw materials , Antimalarial , Antibiotic & Antimicrobial , Medical Disposables , Antifungal Drugs
NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD
Brand: CHENGPENG
Main Products: Veterinary APIS , Veterinary Premix APIs , Veterinary Soluble Powder , Feed Additives , Food Additives , Extracts for Animal
Shenzhou Jiaxin Chemical Co.,Ltd
Brand: JIAXIN
Main Products: Barium Sulphate Precipitated , Sodium Sulphide , Strontium Chloride , Strontium Carbonate , Barium Chloride , Zine Sulfide
Brand: ERA Medicals
Main Products: Medical Instruments , Medicinal Materials , Pharmaceutical Accessories , Medical Disposables , Pharmaceutical Excipients , Medical Supplies
